But also the use of ß-blockers (82.7% vs. 77.5%), ACE inhibitors and angiotensin receptor blockers (80.3% vs. 77.4%) was higher in the diabetes group compared to non-diabetics. The gene discussed is ACE; the disease is diabetes mellitus.